Ellen Weisberg, Martin Sattler. A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3. Haematologica 2012;97(11):1620-1621; https://doi.org/10.3324/haematol.2012.078451.